JP2017529066A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529066A5
JP2017529066A5 JP2017506339A JP2017506339A JP2017529066A5 JP 2017529066 A5 JP2017529066 A5 JP 2017529066A5 JP 2017506339 A JP2017506339 A JP 2017506339A JP 2017506339 A JP2017506339 A JP 2017506339A JP 2017529066 A5 JP2017529066 A5 JP 2017529066A5
Authority
JP
Japan
Prior art keywords
cells
nerve
population
optionally
embryonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506339A
Other languages
English (en)
Japanese (ja)
Other versions
JP6698626B2 (ja
JP2017529066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/043424 external-priority patent/WO2016022472A1/en
Publication of JP2017529066A publication Critical patent/JP2017529066A/ja
Publication of JP2017529066A5 publication Critical patent/JP2017529066A5/ja
Application granted granted Critical
Publication of JP6698626B2 publication Critical patent/JP6698626B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506339A 2014-08-04 2015-08-03 哺乳動物多能性幹細胞、それらの調製のための方法、およびその使用 Expired - Fee Related JP6698626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462032911P 2014-08-04 2014-08-04
US62/032,911 2014-08-04
PCT/US2015/043424 WO2016022472A1 (en) 2014-08-04 2015-08-03 Mammalian pluripotent stem cells, methods for their production, and uses thereof

Publications (3)

Publication Number Publication Date
JP2017529066A JP2017529066A (ja) 2017-10-05
JP2017529066A5 true JP2017529066A5 (enExample) 2018-09-13
JP6698626B2 JP6698626B2 (ja) 2020-05-27

Family

ID=55178918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506339A Expired - Fee Related JP6698626B2 (ja) 2014-08-04 2015-08-03 哺乳動物多能性幹細胞、それらの調製のための方法、およびその使用

Country Status (7)

Country Link
US (2) US20160030484A1 (enExample)
EP (1) EP3194573A4 (enExample)
JP (1) JP6698626B2 (enExample)
CN (1) CN106687582A (enExample)
AU (1) AU2015301342A1 (enExample)
CA (1) CA2957071A1 (enExample)
WO (1) WO2016022472A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6698626B2 (ja) * 2014-08-04 2020-05-27 ユニバーシティ・オブ・カンザス 哺乳動物多能性幹細胞、それらの調製のための方法、およびその使用
CN106222133A (zh) * 2016-06-29 2016-12-14 湛江经济技术开发区海滨医疗器械有限公司 一种利用冲击波使人体间充质干细胞增殖的方法
CN109280682B (zh) * 2018-08-31 2025-09-09 华子昂 增强血管内皮细胞表达p选择素的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003572A1 (en) * 1999-03-05 2003-01-02 David J. Anderson Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
ES2690554T3 (es) * 2008-03-17 2018-11-21 The Scripps Research Institute Enfoques químicos y genéticos combinados para la generación de células madre pluripotentes inducidas
EP2128245A1 (en) 2008-05-27 2009-12-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Generation of induced pluripotent stem (iPS) cells
CN101492676B (zh) * 2008-09-16 2011-02-16 中国科学院广州生物医药与健康研究院 用脑膜细胞生成诱导的多能性干细胞的方法及其用途
KR20110134939A (ko) * 2009-04-03 2011-12-15 더 맥클린 하스피털 코퍼레이션 유도된 다능성 줄기 세포
US8193235B2 (en) * 2009-06-12 2012-06-05 University Of Kansas Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
WO2011013806A1 (ja) * 2009-07-30 2011-02-03 学校法人慶應義塾 シュワン前駆細胞の製造方法及び増殖方法
CN102725399B (zh) 2009-12-18 2015-03-11 上海赛傲生物技术有限公司 制备多能干细胞的材料和方法
EP2537922B1 (en) * 2010-02-18 2021-04-21 Kang Stem Biotech Co., Ltd. Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway
WO2011108766A1 (en) * 2010-03-03 2011-09-09 Kyoto University METHOD FOR DIAGNOSING A PROTEIN MISFOLDING DISEASE USING NERVE CELLS DERIVED FROM iPS CELLS
CN102191221B (zh) * 2010-03-17 2014-11-19 中国人民解放军第二军医大学东方肝胆外科医院 一种能无限自我更新的神经干细胞、其制备方法及其用途
US20120069782A1 (en) * 2010-09-22 2012-03-22 Richard Lee-Chee Kuo Method and apparatus for improving drx in a wireless communication system
US20150159135A1 (en) * 2012-06-15 2015-06-11 Baylor College Of Medicine Perineurium Derived Adult Stem Cells and Methods of Use
JP6698626B2 (ja) * 2014-08-04 2020-05-27 ユニバーシティ・オブ・カンザス 哺乳動物多能性幹細胞、それらの調製のための方法、およびその使用

Similar Documents

Publication Publication Date Title
US20230092739A1 (en) Stem cell compositions and methods of producing stem cells for therapeutic applications
Kim et al. Extensive characterization of feline intra-abdominal adipose-derived mesenchymal stem cells
CN105683360B (zh) 将从间充质干细胞诱导的多能干细胞分化为神经细胞的方法
CN105683359A (zh) 将从间充质干细胞诱导的多能干细胞分化为肝细胞的方法
CN105705632A (zh) 将从间充质干细胞诱导的多能干细胞分化为软骨细胞的方法
JP2017529066A5 (enExample)
Upadhyay Role of regeneration in tissue repairing and therapies
CN106661545B (zh) 制备诱导多能干细胞的方法及由其制备的诱导多能干细胞
CN101906401A (zh) 一种在非接触条件下培养诱导成体骨髓间充质干细胞转变为汗腺细胞的方法
WO2015064800A1 (ko) 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 지방세포로 분화시키는 방법
JP6711758B2 (ja) 間葉系幹細胞から誘導された万能幹細胞を利用して骨芽細胞に分化させる方法
KR102306231B1 (ko) 편도 유래 중간엽 줄기세포로부터 건 세포의 분화방법
Mihalceanu et al. Stem cell therapies for tissue regeneration and wound healing: strategies to enhance therapeutic effectiveness
KR101982835B1 (ko) 중간엽 줄기세포로부터 유도된 만능 줄기세포를 췌장의 베타세포로 분화시키는 방법
JP6700175B2 (ja) 間葉系幹細胞から誘導多能性幹細胞を製造する方法及びその方法によって製造された誘導多能性幹細胞
Upadhyay et al. Stem Cell-Based Regeneration of Salivary Glands: From Bench to Clinics
Murali et al. Harnessing the Potential of Stem Cells from Different Sources for Tissue Engineering
Harman The Equine Mesenchymal Stromal Cell Secretome as a Therapy for Horse Cutaneous Wounds
Birla Cell Therapy for the Heart
Basoli Study of the molecular patterning in stem cells exposed to biophysical stimuli: a new vision of regenerative medicine
TOPCUL et al. Stem Cells in Regenerative Medicine
Marín-García Stem Cells and Mitochondria
Howard-Jones Oral progenitor cells as cell-based treatment for neural damage